Business● Low1h ago · Nov 13, 2026, 6:30 AM
Lineage expects cash runway into Q2 2028 while adding HUNT1 Phase Ib/IIa Huntington’s program
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Lineage, a company, expects to have sufficient cash flow until Q2 2028 and is also adding a new drug development program for Huntington's disease. This indicates a positive financial outlook and expansion in its R&D pipeline.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business11m agoIn Cameroon, Motaze's major maneuvers to finance the 2027 budgetJeune AfriqueBusiness14m agoEx-Eagles player and wife sued for almost $5m over alleged unpaid wages, taxSydney Morning Herald · AustraliaBusiness17m agoSaudi, US business bodies sign MoU to boost trade and investment tiesArab News · Saudi ArabiaBusiness18m agoReig Jofre earns 46% less until September but maintains its sales at 241 millionInfobae · Argentina